Dermatology · Jackson, MS
NPI
1790996544
Since 2007
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2500 N State St, Dept. of Medicine
Jackson, MS, 39216
Phone (601) 984-5601
Groups this clinician bills Medicare through
Medicare paid, 2024
$111K
2,947 services
Medicare patients, 2024
531
Average age 73
Drug cost, 2024
$3.0M
1,145 prescriptions
Company payments, 2025
$57K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeremy D Jackson was code 17003 (destruction skin lesion), 1,183 times for 192 patients. In total Jeremy D Jackson billed 2,947 services in 35 codes, and Medicare paid $111K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-10-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,183 | 192 | $4.03 | $4,762 |
| 99213 Office E&M - Established | Office | 444 | 323 | $56.54 | $25K |
| 17000 Destruction Skin Lesion | Office | 332 | 237 | $33.10 | $11K |
| 99214 Office E&M - Established | Office | 233 | 144 | $78.78 | $18K |
| 17110 Destruction Skin Lesion | Office | 146 | 132 | $71.53 | $10K |
| 11102 Skin Biopsy | Office | 123 | 100 | $61.90 | $7,613 |
| 99212 Office E&M - Established | Office | 80 | 69 | $36.50 | $2,920 |
| 17004 Destruction Skin Lesion | Office | 41 | 28 | $111.32 | $4,564 |
| 11103 Skin Biopsy | Office | 41 | 27 | $33.98 | $1,393 |
| 99203 Office E&M - New | Office | 28 | 28 | $79.95 | $2,238 |
| 11104 Skin Biopsy | Office | 25 | 25 | $82.43 | $2,061 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 24 | 17 | $0.74 | $17.75 |
| 11900 Skin | Office | 20 | 16 | $33.19 | $664 |
| 99204 Office E&M - New | Office | 18 | 18 | $116.65 | $2,100 |
By year: 2022 $112K for 3,014 services; 2023 $99K for 2,729 services; 2024 $111K for 2,947 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeremy D Jackson prescribed most often to Medicare patients was Triamcinolone Acetonide, with 95 prescriptions and refills. In total Jeremy D Jackson wrote 1,145 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 95 | 118 | 49 | $1,556 |
| Ketoconazole Generic | 85 | 114 | 31 | $1,383 |
| Dupixent Pen Dupilumab | 73 | 73 | Under 11 | $265K |
| Remicade Infliximab | 63 | 67 | Under 11 | $621K |
| Clobetasol Propionate Generic | 46 | 48 | 23 | $1,626 |
| Clindamycin Phosphate Generic | 42 | 43 | 15 | $1,664 |
| Humira(Cf) Pen Adalimumab | 37 | 37 | Under 11 | $477K |
| Hydroxyzine Hcl Generic | 36 | 38 | Under 11 | $262 |
| Tacrolimus Generic | 33 | 34 | 17 | $2,040 |
| Hydroxychloroquine Sulfate Generic | 31 | 34 | Under 11 | $398 |
| Otezla Apremilast | 30 | 30 | Under 11 | $133K |
| Mupirocin Generic | 30 | 30 | 17 | $291 |
| Hydrocortisone Generic | 27 | 29 | 14 | $182 |
| Levothyroxine Sodium Generic | 23 | 29 | Under 11 | $82.75 |
| Methotrexate Methotrexate Sodium | 23 | 38 | Under 11 | $232 |
Brand drugs: 363 claims; generic drugs: 782 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeremy D Jackson $57K ($57K in general payments such as food, travel and fees) from 17 companies. The largest payer was Genzyme Corporation with $20K.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 8 | $20K |
| Janssen Biotech, Inc. JNJ | 15 | $18K |
| Abbvie Inc. ABBV | 29 | $18K |
| Novartis Pharmaceuticals Corporation NVS | 19 | $286 |
| Galderma Laboratories, L.P. GALD.SW | 11 | $284 |
| Mallinckrodt Hospital Products Inc. | 5 | $196 |
| Regeneron Healthcare Solutions, Inc. REGN | 6 | $148 |
| LEO Pharma Inc. | 6 | $140 |
| Organon LLC OGN | 5 | $96.67 |
| UCB, Inc. UCB.BR | 2 | $95.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.